Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling

Systemic Sclerosis (SSc) is a disease with limited therapeutic possibilities. Mesenchymal stem cells (MSCs)-therapy could be a promising therapeutic option, however the ideal MSCs source has not yet been found. To address this problem, we perform comparison between bone marrow (BM)-MSCs and adipose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Di Benedetto, Paola, Panzera, Noemi, Cipriani, Paola, Mastroiaco, Valentina, Tessitore, Alessandra, Liakouli, Vasiliki, Ruscitti, Piero, Berardicurti, Onorina, Carubbi, Francesco, Guggino, Giuliana, Bianchi, Andrea, Di Marco, Antinisca, Ciccia, Francesco, Alesse, Edoardo, Giacomelli, Roberto
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509164/
https://ncbi.nlm.nih.gov/pubmed/31073190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-43638-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars